BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Anticancer prodrugs, Lovastatin, rs3825942, ERBB2, calcium channel activity, Kidney)
Bookmark Forward

QuickView for CD19 (gene)


Body Atlas

Most Correlated Tissues

  1. B lymphocyte (IgM memory) of spleen
  2. B lymphocyte (naive) of spleen
  3. Tonsil
  4. Spleen
  5. Lymph nodes
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Common variable immunodeficiency
  2. Infection due to Citrobacter
  3. Chlamydial infection
  4. Bacterial septicemia
  5. Ulceration of intestine
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. emtricitabine
  2. Trinitrobenzenesulfonic Acid
  3. tenofovir
  4. Granulocyte Colony-Stimulating Factor
  5. Radiation
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. TLK2
  2. PTPN6
  3. DVL2
  4. CEBPA
  5. mmu-miR-155-5p
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Sequencing of Anti-CD19 Therapies in the Management of Diffuse Large B-Cell Lymphoma.
  2. Solving the mystery of the FMC63-CD19 affinity.
  3. Incidence of CD19-negative relapse after CD19-targeted immunotherapy in R/R BCP acute lymphoblastic …
  4. CD19-directed T cell-engaging antibodies for the treatment of autoimmune disease.
  5. Clinicopathologic features of relapsed CD19(-) B-ALL in CD19-targeted immunotherapy: Biological insi…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. CD19 hsCAR-T for Refractory/Relapsed CD19+ B-ALL Patients
  2. Humanized CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemi…
  3. CD19 CART Cells for Patients With Relapse and Refractory CD19+ B-cell Lymphoma.
  4. A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed…
  5. 4SCAR-T Therapy Post CD19-targeted Immunotherapy
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.